155 related articles for article (PubMed ID: 21801110)
1. Better clinical results with long term benefits in melasma patients.
Na SY; Cho S; Lee JH
J Dermatolog Treat; 2013 Apr; 24(2):112-8. PubMed ID: 21801110
[TBL] [Abstract][Full Text] [Related]
2. Intense Pulsed Light and Low-Fluence Q-Switched Nd:YAG Laser Treatment in Melasma Patients.
Na SY; Cho S; Lee JH
Ann Dermatol; 2012 Aug; 24(3):267-73. PubMed ID: 22879709
[TBL] [Abstract][Full Text] [Related]
3. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
Ustuner P; Balevi A; Ozdemir M
J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
[TBL] [Abstract][Full Text] [Related]
4. Combination treatment of low-fluence 1,064-nm Q-switched Nd: YAG laser with novel intense pulse light in Korean melasma patients: a prospective, randomized, controlled trial.
Yun WJ; Moon HR; Lee MW; Choi JH; Chang SE
Dermatol Surg; 2014 Aug; 40(8):842-50. PubMed ID: 25022705
[TBL] [Abstract][Full Text] [Related]
5. Low-fluence Q-switched Nd: YAG 1064-nm laser and intense pulsed light for the treatment of melasma.
Vachiramon V; Sirithanabadeekul P; Sahawatwong S
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1339-46. PubMed ID: 25413592
[TBL] [Abstract][Full Text] [Related]
6. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study.
Saleh F; Moftah NH; Abdel-Azim E; Gharieb MG
J Cosmet Dermatol; 2018 Jun; 17(3):319-327. PubMed ID: 29057567
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients.
Yue B; Yang Q; Xu J; Lu Z
Lasers Med Sci; 2016 Nov; 31(8):1657-1663. PubMed ID: 27450275
[TBL] [Abstract][Full Text] [Related]
8. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
[TBL] [Abstract][Full Text] [Related]
9. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
Alsaad SM; Ross EV; Mishra V; Miller L
Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
[TBL] [Abstract][Full Text] [Related]
10. Combination of fractional QSRL and IPL for melasma treatment in Chinese population.
Tong LG; Wu Y; Wang B; Xu XG; Tu HD; Chen HD; Li YH
J Cosmet Laser Ther; 2017 Feb; 19(1):13-17. PubMed ID: 27594596
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers.
Kauvar AN
Lasers Surg Med; 2012 Feb; 44(2):117-24. PubMed ID: 22334295
[TBL] [Abstract][Full Text] [Related]
12. Low-power fractional CO₂ laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study.
Jalaly NY; Valizadeh N; Barikbin B; Yousefi M
Am J Clin Dermatol; 2014 Aug; 15(4):357-63. PubMed ID: 24858737
[TBL] [Abstract][Full Text] [Related]
13. Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser.
Cho HH; Choi M; Cho S; Lee JH
J Dermatolog Treat; 2013 Aug; 24(4):292-6. PubMed ID: 22103770
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of low-fluence 1064-nm Q-switched Nd:YAG laser with or without chemical peeling using Jessner's solution in melasma patients.
Lee DB; Suh HS; Choi YS
J Dermatolog Treat; 2014 Dec; 25(6):523-8. PubMed ID: 24289244
[TBL] [Abstract][Full Text] [Related]
15. Combining Low Power Fractional CO
Esmat S; Z Elramly A; Shahin D; Hilal RF
Lasers Surg Med; 2021 Dec; 53(10):1325-1340. PubMed ID: 34164829
[TBL] [Abstract][Full Text] [Related]
16. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?
Gokalp H; Akkaya AD; Oram Y
J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828
[TBL] [Abstract][Full Text] [Related]
17. The degree of erythema in melasma lesion is associated with the severity of disease and the response to the low-fluence Q-switched 1064-nm Nd:YAG laser treatment.
Park GH; Lee JH; Choi JR; Chang SE
J Dermatolog Treat; 2013 Aug; 24(4):297-9. PubMed ID: 22136311
[No Abstract] [Full Text] [Related]
18. Efficacy and Safety of Topical Silymarin Versus Low Fluence 1064-nm Q Switched Nd:YAG Laser in the Treatment of Melasma: A Comparative Randomized Trial.
Ibrahim SMA; Farag AS; Ali MS; El-Gendy WMAF
Lasers Surg Med; 2021 Dec; 53(10):1341-1347. PubMed ID: 34101206
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of low-fluence 1064 nm Q-switched Nd: YAG laser for the treatment of melasma: A meta-analysis and systematic review.
Chen J; Yu N; Peng L; Li H; Tang Y; Ou S; Zhu H
J Cosmet Dermatol; 2022 Jul; 21(7):. PubMed ID: 35621242
[TBL] [Abstract][Full Text] [Related]
20. Pulse in pulse intense pulsed light for melasma treatment: a pilot study.
Chung JY; Choi M; Lee JH; Cho S; Lee JH
Dermatol Surg; 2014 Feb; 40(2):162-8. PubMed ID: 24433388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
